Cholestech Corporation Urges Consumers to Get Tested During Cholesterol Awareness Month
14 September 2006 - 5:24PM
PR Newswire (US)
Do You Know Your Numbers? HAYWARD, Calif., Sept. 14
/PRNewswire-FirstCall/ -- September is National Cholesterol
Awareness Month, and Cholestech Corporation (NASDAQ:CTEC), a
leading provider of point-of-care health management solutions for
chronic disease, is encouraging all Americans to get tested. If
medical terms like LDL, HDL and triglycerides mean nothing to you,
then September is the time to make getting your cholesterol checked
a priority. The good news is getting tested is now easier than
ever, with mass merchant retailers across the country offering
cholesterol screenings while you shop. According to the American
Heart Association, all Americans aged 20 and over should have a
complete cholesterol screening at least once every five years.
After the screening, your physician or healthcare provider will
inform you of your total cholesterol and individual LDL and HDL
readings. LDL, or low-density lipoprotein, is known as the "bad"
cholesterol. Too much LDL cholesterol can clog your arteries,
increasing your risk of heart attack and stroke. HDL, or
high-density lipoprotein, is known as the "good" cholesterol
because it carries cholesterol away from your arteries. Your body
makes HDL cholesterol for your protection. Studies suggest that
high levels of HDL cholesterol reduce your risk of heart attack.
Cholesterol is a soft, fat-like substance found in the bloodstream
and in all your body's cells. High cholesterol is one of the major
risk factors for heart disease and stroke, but cholesterol also
plays an important role in our health. Your body naturally makes
all the cholesterol it needs to function properly; we also absorb
cholesterol into our blood streams from certain foods. The
saturated fats, trans-fats and cholesterol in some of the foods we
eat can significantly raise your blood cholesterol. There are no
symptoms of high cholesterol, making regular cholesterol screening
a must for all Americans. Having your cholesterol checked is now
easier than ever, as doctors can perform the test in under five
minutes right in their own offices, using proven-accurate,
point-of-care testing systems like the Cholestech LDX(R) to provide
patients with immediate, lab-equivalent results. Point-of-care
testing lets doctors begin immediate counseling for patients whose
readings put them at risk of heart disease. Studies have shown that
providing on-the-spot cholesterol management counseling
significantly increases patient compliance with recommended health
regimens. "To be able to administer the test right in the clinic
and have the results available for the healthcare provider and the
patient to review during the visits is unmatched for
effectiveness," says Donna Gemme, MS-RN, Director of Cardiovascular
Ambulatory Services for UMass Memorial Medical Center in Worcester,
Mass., a university-based lipid clinic that uses the Cholestech LDX
to conduct over 500 screenings per month. "Nothing is better than
face-to-face recognition for patients who are trying so hard and
doing very well to control their lifestyle choices, their diet and
exercise. For patients who aren't achieving their target goals, we
can make an appointment for education and counseling while they're
here. Patients may not always understand all the risk factors of
high cholesterol. Having the results right there with you in the
exam room is really valuable in helping us promote patient
education and healthcare compliance." "Cholesterol management is
imperative to reduce the incidence of coronary heart disease.
Point-of-care testing with the Cholestech LDX system allows
physicians to perform this critical test right in their own offices
during regular exams and provide their patients with immediate
cardiovascular risk assessment," said Warren E. Pinckert II,
president and CEO of Cholestech. "The LDX system has revolutionized
cholesterol screening by providing physicians with laboratory
accurate results in minutes. In addition, the LDX system is
certified by the Cholesterol Reference Method Laboratory Network
(CRMLN), which is the accuracy standard for total cholesterol and
HDL set by the Centers for Disease Control. During National
Cholesterol Month, Cholestech is urging all Americans to know their
numbers and get tested." About Cholestech Cholestech is committed
to enabling people to lead longer, healthier and more active lives.
Cholestech provides easy to use, accessible diagnostic tools and
information to health care practitioners in over 35 countries
around the world. Cholestech offers efficient and economic
diagnostic testing for cholesterol and related lipids, blood
glucose and glycemic control, and liver enzymes at the point of
care. Health care providers can use the CLIA-waived Cholestech
LDX(R) System and the GDX(TM) System(1), which is approved for
prescription home use and hs-CPR for use in moderate complexity
labs, to initiate and monitor the progress of patient therapy. By
providing effective disease management solutions, Cholestech's goal
is to be a leading provider of diagnostic tools and information for
immediate risk assessment and therapeutic monitoring of heart
disease and diabetes. Cholestech LDX(R) is a registered trademark
and Cholestech GDX(TM) is a trademark of Cholestech Corporation.
All other trademarks mentioned in this document are the property of
their respective owners. For more information about Cholestech and
its products visit us on the web at http://www.cholestech.com/ .
(1) GDX is 510(k) cleared for prescription home use and,
accordingly, is CLIA waived. Cholestech Press Contact: Julie Gross
Gelfand HLD/Blankman Public Relations (516) 536-6811 or (212)
896-3926 DATASOURCE: Cholestech Corporation CONTACT: Julie Gross
Gelfand of HLD-Blankman Public Relations, +1-516-536-6811 or
+1-212-896-3926, or , for Cholestech Corporation Web site:
http://www.cholestech.com/
Copyright
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Global X CleanTech ETF (NASDAQ): 0 Nachrichtenartikel
Weitere Cholestech (MM) News-Artikel